ArticleFrontiers in oncology2021

Plasmatic Levels of HSP90α at Diagnosis: A Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors Plus Chemotherapy.

Shubin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.